The clinical efficacy and safety of mesenchymal stromal cells for patients with COVID-19: A systematic review and meta-analysis of randomized controlled trials

The clinical efficacy and safety of mesenchymal stromal cells for patients with COVID-19: A systematic review and meta-analysis of randomized controlled trials

Objectives: This meta-analysis of randomized controlled trials (RCTs) investigated the usefulness of mesenchymal stromal cells (MSCs) to treat patients with COVID-19. Methods: PubMed, Embase, Ovid MEDLINE, the Cochrane Library, and Clinicaltrials.gov were searched for RCTs published before November...

Full description

Bibliographic Details
Main Authors: Ching-Yi Chen, Wang-Chun Chen, Chi-Kuei Hsu, Chien-Ming Chao, Chih-Cheng Lai
Format: Article
Language:English
Published: Elsevier 2022-08-01
Series:Journal of Infection and Public Health
Subjects:
COVID-19
Mesenchymal stromal cell
Mortality
SARS-CoV-2
Online Access:http://www.sciencedirect.com/science/article/pii/S1876034122001794

Internet

http://www.sciencedirect.com/science/article/pii/S1876034122001794

Similar Items